119 related articles for article (PubMed ID: 29069783)
1. TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression.
Yao X; Pham T; Temple B; Gray S; Cannon C; Hardy C; Fletcher K; Ireland SK; Hossain A; Chen R; Abdel-Mageed AB; Biliran H
Oncotarget; 2017 Sep; 8(42):72235-72249. PubMed ID: 29069783
[TBL] [Abstract][Full Text] [Related]
2. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.
Yao X; Gray S; Pham T; Delgardo M; Nguyen A; Do S; Ireland SK; Chen R; Abdel-Mageed AB; Biliran H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1240-1248. PubMed ID: 29170133
[TBL] [Abstract][Full Text] [Related]
4. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
[TBL] [Abstract][Full Text] [Related]
5. The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells.
Yao X; Jennings S; Ireland SK; Pham T; Temple B; Davis M; Chen R; Davenport I; Biliran H
PLoS One; 2014; 9(7):e101564. PubMed ID: 25003198
[TBL] [Abstract][Full Text] [Related]
6. TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.
Brunquell C; Biliran H; Jennings S; Ireland SK; Chen R; Ruoslahti E
Mol Cancer Res; 2012 Nov; 10(11):1482-95. PubMed ID: 22952044
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
8. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM
Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460
[TBL] [Abstract][Full Text] [Related]
10. FAM188B Downregulation Sensitizes Lung Cancer Cells to Anoikis via EGFR Downregulation and Inhibits Tumor Metastasis In Vivo.
Jang EJ; Sung JY; Yoo HE; Jang H; Shim J; Oh ES; Goh SH; Kim YN
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440835
[TBL] [Abstract][Full Text] [Related]
11. Metastasis of tumor cells is enhanced by downregulation of Bit1.
Karmali PP; Brunquell C; Tram H; Ireland SK; Ruoslahti E; Biliran H
PLoS One; 2011; 6(8):e23840. PubMed ID: 21886829
[TBL] [Abstract][Full Text] [Related]
12. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Ko H
Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
[TBL] [Abstract][Full Text] [Related]
13. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.
Hornsveld M; Tenhagen M; van de Ven RA; Smits AM; van Triest MH; van Amersfoort M; Kloet DE; Dansen TB; Burgering BM; Derksen PW
Cell Death Differ; 2016 Sep; 23(9):1483-92. PubMed ID: 27035620
[TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.
Khan P; Manna A; Saha S; Mohanty S; Mukherjee S; Mazumdar M; Guha D; Das T
BMC Cancer; 2016 Jan; 16():39. PubMed ID: 26810856
[TBL] [Abstract][Full Text] [Related]
15. Death Domain-Associated Protein Promotes Colon Cancer Metastasis through Direct Interaction with ZEB1.
Liu Y; Guo F; Zhu X; Guo W; Fu T; Wang W
J Cancer; 2020; 11(3):750-758. PubMed ID: 31942198
[No Abstract] [Full Text] [Related]
16. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression.
Singh T; Prasad R; Katiyar SK
Am J Cancer Res; 2016; 6(6):1287-301. PubMed ID: 27429844
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP; Beland FA; Pogribny IP
Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
[TBL] [Abstract][Full Text] [Related]
19. Negative feedback loop between p66Shc and ZEB1 regulates fibrotic EMT response in lung cancer cells.
Li X; Gao D; Wang H; Li X; Yang J; Yan X; Liu Z; Ma Z
Cell Death Dis; 2015 Apr; 6(4):e1708. PubMed ID: 25837484
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase casein kinase 2-mediated upregulation of N-cadherin confers anoikis resistance on esophageal carcinoma cells.
Ko H; Kim S; Jin CH; Lee E; Ham S; Yook JI; Kim K
Mol Cancer Res; 2012 Aug; 10(8):1032-8. PubMed ID: 22767590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
